Literature DB >> 1909471

A field study of the effect of ivermectin on intestinal helminths in man.

J A Whitworth1, D Morgan, G H Maude, A M McNicholas, D W Taylor.   

Abstract

A single stool specimen from each of 904 villagers participating in a placebo-controlled trial of ivermectin for onchocerciasis was examined for intestinal helminths by the formol-ether technique. Ivermectin had a significant effect on Ascaris infection, reducing prevalence and intensity for at least 3 months, but rapid reinfection occurred. There was no significant effect on Trichuris, Necator or Schistosoma mansoni infections. Incidental Strongyloides infections were not seen commonly in this population, but were significantly reduced in the ivermectin-treated group. Regular administration of ivermectin on a mass basis would reduce the prevalence of Ascaris infection and any attendant morbidity. This is a useful additional effect of the drug.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909471     DOI: 10.1016/0035-9203(91)90037-y

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  12 in total

1.  Effects of annual mass treatment with ivermectin for onchocerciasis on the prevalence of intestinal helminths.

Authors:  Julie Gutman; Emmanuel Emukah; Njideka Okpala; Chinyere Okoro; Andrew Obasi; Emmanuel S Miri; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

2.  Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.

Authors:  Mandy Juarez; Alejandro Schcolnik-Cabrera; Guadalupe Dominguez-Gomez; Alma Chavez-Blanco; Jose Diaz-Chavez; Alfonso Duenas-Gonzalez
Journal:  Cancer Chemother Pharmacol       Date:  2020-05-30       Impact factor: 3.333

Review 3.  Ivermectin for onchocercal eye disease (river blindness).

Authors:  Henry O D Ejere; Ellen Schwartz; Richard Wormald; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 4.  Anthelmintics. A comparative review of their clinical pharmacology.

Authors:  N de Silva; H Guyatt; D Bundy
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 5.  Broadening the range of use cases for ivermectin - a review of the evidence.

Authors:  Christian Kositz; John Bradley; Harry Hutchins; Anna Last; Umberto D'Alessandro; Michael Marks
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-03-02       Impact factor: 2.455

6.  Impact of long-term treatment with ivermectin on the prevalence and intensity of soil-transmitted helminth infections.

Authors:  Ana Lucia Moncayo; Maritza Vaca; Leila Amorim; Alejandro Rodriguez; Silvia Erazo; Gisela Oviedo; Isabel Quinzo; Margarita Padilla; Martha Chico; Raquel Lovato; Eduardo Gomez; Mauricio L Barreto; Philip J Cooper
Journal:  PLoS Negl Trop Dis       Date:  2008-09-10

7.  Anthelmintic drugs for treating ascariasis.

Authors:  Lucieni O Conterno; Marilia D Turchi; Ione Corrêa; Ricardo Augusto Monteiro de Barros Almeida
Journal:  Cochrane Database Syst Rev       Date:  2020-04-14

8.  African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.

Authors:  Stanimira P Krotneva; Luc E Coffeng; Mounkaila Noma; Honorat G M Zouré; Lalle Bakoné; Uche V Amazigo; Sake J de Vlas; Wilma A Stolk
Journal:  PLoS Negl Trop Dis       Date:  2015-09-24

9.  Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni.

Authors:  Gordana Panic; Mireille Vargas; Ivan Scandale; Jennifer Keiser
Journal:  PLoS Negl Trop Dis       Date:  2015-07-31

Review 10.  Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection.

Authors:  Cesar Henriquez-Camacho; Eduardo Gotuzzo; Juan Echevarria; A Clinton White; Angelica Terashima; Frine Samalvides; José A Pérez-Molina; Maria N Plana
Journal:  Cochrane Database Syst Rev       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.